OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $750,000 Invested

2023

NeuroDex

Erez Eitan, PhD

Clinical Validation of a Robust Blood Test Using Neuron-Derived Exosomes For Detection Of Alpha-Synuclein/TDP43 Pathologies in Patients With Alzheimer’s Disease

  • Funding Amount: $750,000
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Target: Synuclein
  • Status: Active